Emory Study Links High-Dose Vitamin D to Improved Cognitive Scores in At-Risk Seniors

A new observational study from Emory University indicates that older adults with mild cognitive impairment and sleep disturbances may experience better cognitive performance when taking high daily doses of vitamin D. The research, published in the journal Sleep Medicine, suggests that supplementing with 5,000 international units or more daily is associated with higher scores on standard cognitive assessments. While the study does not prove causation, it highlights vitamin D as a potentially modifiable factor for supporting brain health in individuals at elevated risk for progressing to Alzheimer's disease.
Key points
- Researchers at Emory University analyzed data from 54 participants diagnosed or suspected of having mild cognitive impairment alongside sleep problems.
- Participants who consumed 5,000 international units or more of vitamin D daily scored higher on the Montreal Cognitive Assessment than those who took no supplement.
- The cognitive benefits observed were consistent regardless of whether the participants took vitamin D2 (plant/fungi-derived) or vitamin D3 (sun/animal-derived).
- The study emphasizes that this finding represents an association rather than causation, and further clinical trials are needed to confirm if supplementation can effectively improve cognition.
- The findings were published in the October 2026 issue of the journal Sleep Medicine, with senior author Dr. Victoria Pak noting the importance of early intervention windows.
Background
This finding builds on earlier coverage from August and September 2026, which reported similar results from the same Emory University study. Previous reports noted that high-dose vitamin D users scored approximately 13% higher on cognitive tests compared to non-users, with some analyses suggesting a four-point boost on the Montreal Cognitive Assessment. Earlier coverage also highlighted that while the results were promising, they were preliminary and did not establish a causal link, with researchers urging larger clinical trials to validate the findings. The current report confirms these details and adds the specific publication date and journal information.
Why it matters
As rates of Alzheimer's disease continue to rise, identifying accessible and modifiable factors like vitamin D intake could offer new strategies for supporting brain health during the early stages of cognitive decline. The study suggests that for older adults experiencing both sleep disturbance and mild cognitive impairment, there may be a critical window for intervention where such supplements could help maintain cognitive function before progression to more severe dementia.
What to watch
The research team calls for larger clinical trials to determine whether vitamin D supplementation can meaningfully improve cognition in people with early cognitive changes. While the current study shows an association, it cannot prove that high doses cause better cognitive outcomes. Future research will need to establish causality and determine optimal dosages, while also considering individual variations in vitamin D needs and potential interactions with other health factors.
Want the full story? Read the original reporting
Read on Sci.News